168 related articles for article (PubMed ID: 31264167)
1. Influx rate of
Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
[TBL] [Abstract][Full Text] [Related]
2.
Yang H; Jenni S; Colovic M; Merkens H; Poleschuk C; Rodrigo I; Miao Q; Johnson BF; Rishel MJ; Sossi V; Webster JM; Bénard F; Schaffer P
J Nucl Med; 2017 Mar; 58(3):367-373. PubMed ID: 27789715
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive Use of Positron Emission Tomography to Monitor Diethyl maleate and Radiation-Induced Changes in System x
Čolović M; Yang H; Merkens H; Colpo N; Bénard F; Schaffer P
Mol Imaging Biol; 2019 Dec; 21(6):1107-1116. PubMed ID: 30838549
[TBL] [Abstract][Full Text] [Related]
4. Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.
Webster JM; Morton CA; Johnson BF; Yang H; Rishel MJ; Lee BD; Miao Q; Pabba C; Yapp DT; Schaffer P
J Nucl Med; 2014 Apr; 55(4):657-64. PubMed ID: 24578242
[TBL] [Abstract][Full Text] [Related]
5. Comparative Evaluation of [
Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Chirality on the Application of 5-[
Čolović M; Yang H; Merkens H; Colpo N; Bénard F; Schaffer P
Mol Imaging Biol; 2020 Aug; 22(4):873-882. PubMed ID: 31792837
[TBL] [Abstract][Full Text] [Related]
7. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
[TBL] [Abstract][Full Text] [Related]
8. Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.
Pitman KE; Rusten E; Kristian A; Malinen E
Acta Oncol; 2015; 54(9):1399-407. PubMed ID: 26217987
[TBL] [Abstract][Full Text] [Related]
9. Dynamic 2-Deoxy-2-[
Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
11. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
[TBL] [Abstract][Full Text] [Related]
12. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950
[TBL] [Abstract][Full Text] [Related]
13. Addressing Chirality in the Structure and Synthesis of [
Yang H; Tam B; Čolović M; Southcott L; Merkens H; Bénard F; Schaffer P
Chemistry; 2017 Aug; 23(46):11100-11107. PubMed ID: 28744973
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
Koukouraki S; Strauss LG; Georgoulias V; Eisenhut M; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1115-22. PubMed ID: 16763820
[TBL] [Abstract][Full Text] [Related]
15. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
16. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E
Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812
[TBL] [Abstract][Full Text] [Related]
17. Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism.
Koglin N; Mueller A; Berndt M; Schmitt-Willich H; Toschi L; Stephens AW; Gekeler V; Friebe M; Dinkelborg LM
Clin Cancer Res; 2011 Sep; 17(18):6000-11. PubMed ID: 21750203
[TBL] [Abstract][Full Text] [Related]
18. Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts.
Kristian A; Nilsen LB; Røe K; Revheim ME; Engebråten O; Mælandsmo GM; Holm R; Malinen E; Seierstad T
Nucl Med Mol Imaging; 2013 Sep; 47(3):173-80. PubMed ID: 24900104
[TBL] [Abstract][Full Text] [Related]
19. PET Imaging of Hepatocellular Carcinomas:
Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G
Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682
[TBL] [Abstract][Full Text] [Related]
20. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
Strauss LG; Dimitrakopoulou-Strauss A; Haberkorn U
J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]